Navigation Links
MacroGenics to Receive $10 Million Milestone Payment from Servier for Dosing the First Patient in a Phase 1 Dose Expansion Trial of MGA271
Date:8/20/2013

roGenics granted Servier an option to obtain an exclusive license to develop and commercialize MGA271 in all countries other than the United States, Canada, Mexico, Japan, South Korea and India.  MacroGenics received a $20 million option grant fee up-front, will receive a $10 million milestone payment in the third quarter of 2013 in connection with the enrollment of the first patient in the Phase 1 dose expansion trial and may be eligible to receive up to an additional approximately $410 million in license grant fees, and clinical, development, regulatory and sales milestone payments.

About MacroGenics, Inc.

MacroGenics is a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases.  The company generates its pipeline of product candidates from its proprietary suite of next-generation antibody technology platforms, which it believes improve the performance of monoclonal antibodies and antibody-derived molecules.  The company creates both differentiated molecules that are directed to novel cancer targets, as well as "bio-betters," which are drugs designed to improve upon marketed medicines.  The combination of MacroGenics' technology platforms and antibody engineering expertise has allowed the company to generate promising product candidates and enter into several strategic collaborations with global pharmaceutical and biotechnology companies.   www.macrogenics.com

Statements made in this press release that are not historical facts are forward-looking statements. Words such as "expects," "believes," "intends," and similar expressions are intended to identify forward-looking statements. Actual results may differ materially f
'/>"/>

SOURCE MacroGenics, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ImaginAb and MacroGenics Collaborate to Develop In Vivo Imaging Agents for Autoimmune Diseases, Cancer
2. MacroGenics Appoints Jon Wigginton, M.D., as Senior Vice President, Clinical Development
3. PAREXEL Chief Operating Officer Dr. Mark A. Goldberg Receives Special Recognition Award
4. Leica Biosystems Receives FDA Approval for the Fully Automated Bond Oracle™ HER2 IHC System on the Leica BOND-MAX
5. Galenea to Receive $6 Million From The Stanley Medical Research Institute to Progress Pro-Cognitive Drug Discovery and Development Program
6. Retired Pro Hockey Player 1st to Receive Total Artificial Heart in Upstate New York
7. Sensitech Inc. Products Receive Regulatory Compliance Approval from IATA
8. Nephros Receives 510(k) Clearance for Hemodiafiltration System
9. ProUroCare Medical Receives FDA Clearance for ProUroScan Elasticity Imaging System
10. BONESUPPORT Receives Red Herring 2012 Top 100 Europe Award
11. Diabecline Antibiotic Receives Edison Award for Best New Pharmaceutical Product
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2015)... 2015  InMed Pharmaceuticals Inc. ("InMed") (CSE: IN; ... a provisional patent application with the United States ... treatment of Epidermolysis Bullosa Simplex (EBS) using novel ... Dr. Sazzad Hossain , ... excited to file our first patent covering the ...
(Date:5/25/2015)... Chain Drugstore Ltd. (NYSE: NPD ) ("Nepstar" or the ... on the number of directly operated stores, today announced ... 31, 2015. Financial Highlights , Same ... quarter of 2014 , Revenue increased by 11.9% ... the first quarter of 2014 , Net loss ...
(Date:5/22/2015)... , May 22 2015 /CNW/ - The Taskforce representing ... very appreciative of all the hard work that the Minister ... past six months. This program recognizes the needs of the ... at least $75,000 a year, tax free, with annual adjustments ... be eligible for annual payments of $100,000 based on the ...
Breaking Medicine Technology:InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 2InMed Pharmaceuticals Files Provisional Patent Covering Novel Compounds for Treating Epidermolysis Bullosa Simplex (EBS) 3China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 2China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 3China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 4China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 5China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 6China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 7China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 8China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 9China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 10China Nepstar Chain Drugstore Ltd. Reports First Quarter 2015 Financial Results 11
... MOUNTAIN VIEW, Calif., Feb. 28, 2011 VIVUS, ... to the development and commercialization of novel therapeutic products, today ... and year ended December 31, 2010. ... development program, we successfully completed the two-year SEQUEL study, an ...
... The staffs of Chiltern International Limited (Chiltern), a global ... 25 year mark of their successful collaboration in Drug ... have worked together using a validated and regulatory accepted ... assessment of drug phototoxicity. The history of this collaboration ...
Cached Medicine Technology:VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 2VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 3VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 4VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 5VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 6VIVUS Reports 2010 Fourth Quarter and Full-Year Financial Results 7Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 2Chiltern - Spectratox Drug Photoxicity Collaboration Celebrates 25 Years 3
(Date:5/26/2015)... 2015 Foot and Ankle Specialists ... J. Leone (Pasadena and Baltimore Divisions) was recently ... Podiatric Medical Association (MPMA) President from 2013 to 2015 ... his Doctorate in Podiatric Medicine from Temple University in ... Hospital in Voorhees, New Jersey. Dr. Leone is ...
(Date:5/26/2015)... Santa Barbara, CA (PRWEB) May 26, 2015 ... its 2015 commencement ceremonies during the Memorial Day ... students. The ceremonies occurred on Pacifica’s picturesque Ladera ... Graduates, family, friends, faculty, and alumni traveled to ... attend these special events. , The ...
(Date:5/26/2015)... 26, 2015 The Brain Aneurysm Foundation ... Pops and their renowned Conductor Keith Lockhart will once ... evening, June 10, 2015—the 4th Annual Brain Aneurysm ... Pops Night is set to feature an exclusive Brain ... Keith Lockhart who tragically lost his sister-in-law to a ...
(Date:5/26/2015)... The professionals from Marietta Vet Clinic ... helping local rescue pets with a parking lot cookout ... Kimmerling DDS, Suzanna Aguilera DMD and Garrick McGrath DMD ... 100% of proceeds from the extravaganza. , Tents, grills ... to help save unwanted, local animals. Doctors and ...
(Date:5/26/2015)... NC (PRWEB) May 26, 2015 Carl ... at Pinehurst Surgical Center in Pinehurst, N.C. have launched ... sinus surgery patients about chronic sinusitis and the benefits ... that can be used to determine if someone is ... questions about symptoms and other factors that can contribute ...
Breaking Medicine News(10 mins):Health News:Foot and Ankle Specialists of the Mid-Atlantic, LLC Podiatrist Receives MPMA Service Award 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 2Health News:Pacifica Graduate Institute Hosted its 2015 Commencement Ceremonies over Memorial Day Weekend 3Health News:Boston Pops & Renowned Conductor Keith Lockhart to Join the Brain Aneurysm Foundation for the 4th Annual Brain Aneurysm Foundation Night at the Pops 2Health News:"Rescue Animal Cookout" Announced at Verde Pointe Professional Park on June 25, 2015 2Health News:Pinehurst Surgical Sinus Center Launches Pinehurst Balloon Sinuplasty Website 2
... tested in clinical trials may have potentially adverse side ... with mice suggests the drugs could act like a ... with their ability to send messages to the brain. ... led to the drug development, are published in the ...
... N.Y. -- University at Buffalo researchers are expressing concern ... a common bacterium that has surfaced in the U.S. ... Klebsiella pneumoniae have caused infections mostly ... compromised," says Thomas Russo, MD, professor in the Department ...
... Education (AGHE) the educational branch of The Gerontological ... Meeting and Educational Leadership Conference from February 23 to ... Arlington, VA. Media representatives are invited to attend free ... professionals in the field of aging to present their ...
... , FRIDAY, Feb. 17 (HealthDay News) --,Children with ... to frequent absences that are largely the result of ... itself, a new study finds. Researchers from Nationwide ... to 17 years with and without inflammatory bowel disease ...
... benefit everyone including those without school-aged children and ... to a study by two Michigan State University scholars. ... often argue they should be exempt from paying school taxes ... true, argues Zachary Neal, sociologist and lead researcher on the ...
... The Newcastle team who helped develop the FAST system to identify ... treatment for stroke patients. Having developed the FAST acronym ... TV ads, the University and NHS team are now trying out ... their medical team work out which course of treatment is most ...
Cached Medicine News:Health News:Alzheimer's drugs may have adverse side effects 2Health News:Nasty 'superbug' is being studied by UB researchers 2Health News:Nasty 'superbug' is being studied by UB researchers 3Health News:Meeting to outline effective education about aging as America's senior population grows 2Health News:Kids With Crohn's Disease, Colitis Often Struggle at School: Study 2Health News:No kids in public school? You still benefit 2Health News:Dash to help - new app to improve stroke treatment 2Health News:Dash to help - new app to improve stroke treatment 3
... VITALITY 2 implantable cardioverter defibrillators (ICDs) are ... sudden cardiac death (SCD) due to arrhythmia. ... VITALITY 2 ICD is designed to facilitate ... comfort., ,The VITALITY 2 system incorporates Guidant's ...
... portable ultrasound system which connects via USB or ... computer. The large display allows the entire scan ... the need for scrolling and changing back and ... the A-Scan 100 include built-in algorithms for difficult ...
... designed for fast and simple operation. Tone-assisted ... is aligned & measurements are recorded. The ... use in the IOL calculation. The AL-100 ... accuracy of 0.1mm and a resolution of ...
... an extremely accurate digital A-scan system. The ... probe and fast precise algorithm enables scan ... along the visual axis. The A5500 A-scan ... monitor, built-in thermal printer, 5 different examination ...
Medicine Products: